Renna Karoline Eloi Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renna Karoline Eloi Costa has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Douglas Adamoski
Centro Nacional de Pesquisa em Energia e Materiais, Brasil
2 shared publications Alexandre Cassago
Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, Brazil
1 shared publication- Alliny Cristiny da Silva Bastos
16Division of Oncology, Section of Medical Oncology, Washington University School of Medicine (WashU Medicine), St. Louis, Missouri
1 shared publication Andre L.B. Ambrosio
1 shared publication- Andre Luis Berteli Ambrosio
São Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil
1 shared publication - Anna Maria Steyer
EMBL Imaging Centre, European Molecular Biology Laboratory, Heidelberg, Germany
1 shared publication
Latest Publications
- Open Access
- 21 November 2023
- Published by Universidade Estadual de Campinas
Desenvolvimento de novos inibidores da enzima glutaminase com potencial ação antitumoral
- 21 November 2023
- Published by Universidade Estadual de Campinas
Open AccessDesenvolvimento de novos inibidores da enzima glutaminase com potencial ação antitumoral
- 19 October 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (12) , 1902-1912
Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection
Glutaminase (GLS), which deaminates glutamine to form glutamate, is a mitochondrial tetrameric protein complex. Although inorganic phosphate (Pi) is known to promote GLS filamentation and activation, the molecular basis of this mechanism is unknown. Here we aimed to determine the molecular mechanism of Pi-induced mouse GLS filamentation and its impact on mitochondrial physiology. Single-particle cryogenic electron microscopy revealed an allosteric mechanism in which Pi binding at the tetramer interface and the activation loop is coupled to direct nucleophile activation at the active site. The active conformation is prone to enzyme filamentation. Notably, human GLS filaments form inside tubulated mitochondria following glutamine withdrawal, as shown by in situ cryo-electron tomography of cells thinned by cryo-focused ion beam milling. Mitochondria with GLS filaments exhibit increased protection from mitophagy. We reveal roles of filamentous GLS in mitochondrial morphology and recycling.
- 19 October 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (12) , 1902-1912
Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection
Glutaminase (GLS), which deaminates glutamine to form glutamate, is a mitochondrial tetrameric protein complex. Although inorganic phosphate (Pi) is known to promote GLS filamentation and activation, the molecular basis of this mechanism is unknown. Here we aimed to determine the molecular mechanism of Pi-induced mouse GLS filamentation and its impact on mitochondrial physiology. Single-particle cryogenic electron microscopy revealed an allosteric mechanism in which Pi binding at the tetramer interface and the activation loop is coupled to direct nucleophile activation at the active site. The active conformation is prone to enzyme filamentation. Notably, human GLS filaments form inside tubulated mitochondria following glutamine withdrawal, as shown by in situ cryo-electron tomography of cells thinned by cryo-focused ion beam milling. Mitochondria with GLS filaments exhibit increased protection from mitophagy. We reveal roles of filamentous GLS in mitochondrial morphology and recycling.
- Open Access
- 10 February 2023
- Published by Elsevier in Results in Chemistry
- Vol. 5
Discovery of aminothiazole derivatives as a chemical scaffold for glutaminase inhibition
- 10 February 2023
- Published by Elsevier in Results in Chemistry
- Vol. 5
Open AccessDiscovery of aminothiazole derivatives as a chemical scaffold for glutaminase inhibition